Monthly
US$200
Billed every month
Sign in to subscribeMupirocin Ointment
Matched- Active ingredients (original)
- MUPIROCIN
- Dosage form (original)
- OINTMENT
- Route (original)
- TOPICAL
Read these limits
- US patent expiration does not establish Chinese patent expiration. Dates here come from the US Orange Book; Chinese patent status needs separate checking.
- The Orange Book lists holder-submitted patents and does not cover all related patents.
- “Unmatched” means no English ingredient-name counterpart in the Chinese official-name sources loaded here; it does not mean no Chinese approval or filing. A zero count means a Chinese name is matched but no records were found in the loaded source. Source dates appear below.
- This page contains no sales or market-size data and cannot establish development value.
- Names on unmatched rows are the original FDA Orange Book names, without Chinese translation. The same ingredient may have a different generic name in China.
US-approved products
Application numbers, product numbers and original fields are retained. Marketing status is shown as listed in the source.
Earliest approval1987/12/31
ANDA applications6
RLD applicantGLAXOSMITHKLINE
Currently marketed products: 6 · Counts FDA prescription and OTC marketing categories as listed; discontinued or unknown categories are excluded.
| Application / product number | Brand name (original) | Applicant (original) | Dosage form (original) | Route (original) | Strength (original) | Earliest approval | RLD / RS | Marketing status (original) | Official source |
|---|---|---|---|---|---|---|---|---|---|
| A065085-001 | MUPIROCIN | TEVA PHARMACEUTICALS USA INC | OINTMENT | TOPICAL | MUPIROCIN: 2% | 2003/11/07 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A065123-001 | MUPIROCIN | PADAGIS ISRAEL PHARMACEUTICALS LTD | OINTMENT | TOPICAL | MUPIROCIN: 2% | 2003/11/07 | N / Y | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A065170-001 | MUPIROCIN | SUN PHARMA CANADA INC | OINTMENT | TOPICAL | MUPIROCIN: 2% | 2005/09/23 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A065192-001 | MUPIROCIN | FOUGERA PHARMACEUTICALS INC | OINTMENT | TOPICAL | MUPIROCIN: 2% | 2005/11/30 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A090480-001 | MUPIROCIN | GLENMARK PHARMACEUTICALS INC USA | OINTMENT | TOPICAL | MUPIROCIN: 2% | 2011/06/08 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A217943-001 | MUPIROCIN | ENCUBE ETHICALS PRIVATE LTD | OINTMENT | TOPICAL | MUPIROCIN: 2% | 2025/05/13 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| N050591-001 | BACTROBAN | GLAXOSMITHKLINE | OINTMENT | TOPICAL | MUPIROCIN: 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 1987/12/31 | Y / N | DISCONTINUED | openFDA ↗ |
| N050788-001 | CENTANY | PADAGIS US LLC | OINTMENT | TOPICAL | MUPIROCIN: 2% | 2002/12/04 | N / N | DISCONTINUED | openFDA ↗ |
Listed US patents
*PED rows, substance/product flags, use codes and delisting-request flags are retained without determining legal effect.
Latest listed patent expiration—
Substance patent expiration (DS flag)—
This column includes only source rows explicitly flagged DS. A PED row without that flag is not assigned one by this site.
| Application / product number | Patent number | Listed expiration | Substance / product flags | Use code | Delisting request | Official source |
|---|---|---|---|---|---|---|
| Not listed | ||||||
Exclusivity source records
FDA exclusivity code list ↗Latest exclusivity expiration: —
| Application / product number | Exclusivity code | Listed expiration | Official source |
|---|---|---|---|
| Not listed | |||
Chinese record details
Chinese product landscape ↗The four-zero filter applies only to matched rows: catalog holders, NHSA approval numbers, applications under review, and companies filing generics this year. Unmatched rows have no Chinese counts. Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Catalog holders 0
| Company (original) | Identifier (original) | Source date | Official source |
|---|---|---|---|
| No matching records in this loaded source. | |||
NHSA approval numbers 33
| Company (original) | Identifier (original) | Source date | Official source |
|---|---|---|---|
| Beijing Bei Lu Pharma Co., Ltd. romanized | 国药准字H202641912%(10g:0.2g) | — | Official source ↗ |
| Beijing Xie He Pharmaceutical Factory romanized | 国药准字H201833022% | — | Official source ↗ |
| Guangdong Heng Jian Pharmaceutical Co., Ltd. romanized | 国药准字H201832942% | — | Official source ↗ |
| Zhuhai Lian Bang Pharmaceutical Co., Ltd. Zhong Shan Branch romanized | 国药准字H202496492%(5g:0.1g) | — | Official source ↗ |
| Zhong Mei Tianjin Shi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H109300642% | — | Official source ↗ |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H202440942%(15g:0.3g) | — | Official source ↗ |
| Suzhou Tian Ma Pharmaceuticals Group Tian Ji Biopharmaceutical Co., Ltd. romanized | 国药准字H202653282%(10g:0.2g) | — | Official source ↗ |
| Hebei Xin Zhang Yao Co., Ltd. romanized | 国药准字H202630382%(15g:0.3g) | — | Official source ↗ |
| Henan Ling Rui Pharmaceutical Co., Ltd. romanized | 国药准字H202492032%(15g:0.3g) | — | Official source ↗ |
| Shandong Liang Fu Pharmaceutical Co., Ltd. romanized | 国药准字H202433322%(15g:0.3g) | — | Official source ↗ |
| Hangzhou Zhu Yang Xin Pharma Co., Ltd. romanized | 国药准字H201733892% | — | Official source ↗ |
| Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | 国药准字H202639422%(15g:0.3g) | — | Official source ↗ |
| Jiangxi Shimei Pharmaceutical Co., Ltd | 国药准字H202556752%(15g:0.3g) | — | Official source ↗ |
| Hainan Quan Xing Pharmaceutical Co., Ltd. romanized | 国药准字H201930362%(5g:0.1g) | — | Official source ↗ |
| Hainan Hai Shen Tong Zhou Pharmaceutical Co., Ltd. romanized | 国药准字H202640182%(15g:0.3g) | — | Official source ↗ |
| Li Cai Gansu Xi Feng Pharmaceutical Co., Ltd. romanized | 国药准字H202530432%(15g:0.3g) | — | Official source ↗ |
| Hubei Cheng Tian Pharma Co., Ltd. romanized | 国药准字H201330672% | — | Official source ↗ |
| Ao Mei Pharmaceutical Factory Co., Ltd. romanized | 国药准字HC201600152% | — | Official source ↗ |
| Fu Yuan Pharma Co., Ltd. romanized | 国药准字H202138522% | — | Official source ↗ |
| Hubei Shu Huo Pharma Co., Ltd. romanized | 国药准字H202633132%(15g:0.3g) | — | Official source ↗ |
| Jiangsu Ziyond Pharmaceutical Co., Ltd. | 国药准字H202494322%(15g:0.3g) | — | Official source ↗ |
| Wuhan Jiang Cheng Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20244211See source | — | Official source ↗ |
| Beijing Jing Feng Pharmaceutical (Hebei) Co., Ltd. romanized | 国药准字H201830012%(5g: 0.1g) | — | Official source ↗ |
| Beijing Bao Nian Tang (He Ze) Pharma Co., Ltd. romanized | 国药准字H202633902%(15g:0.3g) | — | Official source ↗ |
| Hainan Zi Cheng Zhong Tou Bio Technology Co., Ltd. romanized | 国药准字H202540832%(15g:0.3g) | — | Official source ↗ |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20254639See source | — | Official source ↗ |
| Zhejiang Zhong Yan Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H202558892%(10g:0.2g) | — | Official source ↗ |
| Suzhou Gao Mai Pharma Co., Ltd. romanized | 国药准字H20265065See source | — | Official source ↗ |
| Shenzhen Shi Tai Li Biopharmaceuticals Co., Ltd. romanized | 国药准字H202551252%(15g:0.3g) | — | Official source ↗ |
| Beijing Foyou Pharma CO.,LTD | 国药准字H202530112%(15g:0.3g) | — | Official source ↗ |
| Shandong Liang Fu Pharmaceutical Co., Ltd. romanized | 国药准字H202433322%(15g:0.3g) | — | Official source ↗ |
| Ao Mei Pharmaceutical Factory Co., Ltd. romanized | 国药准字HC201600152% | — | Official source ↗ |
| Fu Yuan Pharma Co., Ltd. romanized | 国药准字H202138522% | — | Official source ↗ |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20254639See source | — | Official source ↗ |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20254639See source | — | Official source ↗ |
| Guangdong Heng Jian Pharmaceutical Co., Ltd. romanized | 国药准字H201832942% | — | Official source ↗ |
| Zhong Mei Tianjin Shi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H109300642% | — | Official source ↗ |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H202692012%(10g:0.2g) | — | Official source ↗ |
| Hangzhou Zhu Yang Xin Pharma Co., Ltd. romanized | 国药准字H201733892% | — | Official source ↗ |
| Hainan Quan Xing Pharmaceutical Co., Ltd. romanized | 国药准字H201930362%(5g:0.1g) | — | Official source ↗ |
| Hubei Cheng Tian Pharma Co., Ltd. romanized | 国药准字H201330672% | — | Official source ↗ |
| Ao Mei Pharmaceutical Factory Co., Ltd. romanized | 国药准字HC201600152% | — | Official source ↗ |
| Fu Yuan Pharma Co., Ltd. romanized | 国药准字H202138522% | — | Official source ↗ |
| Hubei Shu Huo Pharma Co., Ltd. romanized | 国药准字H202633132%(15g:0.3g) | — | Official source ↗ |
| Beijing Jing Feng Pharmaceutical (Hebei) Co., Ltd. romanized | 国药准字H201830012%(5g: 0.1g) | — | Official source ↗ |
| Shenzhen Shi Tai Li Biopharmaceuticals Co., Ltd. romanized | 国药准字H202551252%(15g:0.3g) | — | Official source ↗ |
| Guangdong Heng Jian Pharmaceutical Co., Ltd. romanized | 国药准字H201832942% | — | Official source ↗ |
| Zhong Mei Tianjin Shi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H109300642% | — | Official source ↗ |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H202692022%(5g:0.1g) | — | Official source ↗ |
| Hangzhou Zhu Yang Xin Pharma Co., Ltd. romanized | 国药准字H201733892% | — | Official source ↗ |
| Hainan Quan Xing Pharmaceutical Co., Ltd. romanized | 国药准字H201930362%(5g:0.1g) | — | Official source ↗ |
| Hubei Cheng Tian Pharma Co., Ltd. romanized | 国药准字H201330672% | — | Official source ↗ |
| Ao Mei Pharmaceutical Factory Co., Ltd. romanized | 国药准字HC201600152% | — | Official source ↗ |
| Fu Yuan Pharma Co., Ltd. romanized | 国药准字H202138522% | — | Official source ↗ |
| Beijing Jing Feng Pharmaceutical (Hebei) Co., Ltd. romanized | 国药准字H201830012%(5g: 0.1g) | — | Official source ↗ |
| Shenzhen Shi Tai Li Biopharmaceuticals Co., Ltd. romanized | 国药准字H202551252%(15g:0.3g) | — | Official source ↗ |
| Ao Mei Pharmaceutical Factory Co., Ltd. romanized | 国药准字HC201600152% | — | Official source ↗ |
| Fu Yuan Pharma Co., Ltd. romanized | 国药准字H202138522% | — | Official source ↗ |
| Guangdong Heng Jian Pharmaceutical Co., Ltd. romanized | 国药准字H201832942% | — | Official source ↗ |
| Hangzhou Zhu Yang Xin Pharma Co., Ltd. romanized | 国药准字H201733892% | — | Official source ↗ |
| Hainan Quan Xing Pharmaceutical Co., Ltd. romanized | 国药准字H201930362%(5g:0.1g) | — | Official source ↗ |
| Hubei Cheng Tian Pharma Co., Ltd. romanized | 国药准字H201330672% | — | Official source ↗ |
| Ao Mei Pharmaceutical Factory Co., Ltd. romanized | 国药准字HC201600152% | — | Official source ↗ |
| Fu Yuan Pharma Co., Ltd. romanized | 国药准字H202138522% | — | Official source ↗ |
| Beijing Jing Feng Pharmaceutical (Hebei) Co., Ltd. romanized | 国药准字H201830012%(5g: 0.1g) | — | Official source ↗ |
| Guangdong Heng Jian Pharmaceutical Co., Ltd. romanized | 国药准字H201832942% | — | Official source ↗ |
| Hangzhou Zhu Yang Xin Pharma Co., Ltd. romanized | 国药准字H201733892% | — | Official source ↗ |
| Hainan Quan Xing Pharmaceutical Co., Ltd. romanized | 国药准字H201930362%(5g:0.1g) | — | Official source ↗ |
| Hubei Cheng Tian Pharma Co., Ltd. romanized | 国药准字H201330672% | — | Official source ↗ |
| Fu Yuan Pharma Co., Ltd. romanized | 国药准字H202138522% | — | Official source ↗ |
| Beijing Jing Feng Pharmaceutical (Hebei) Co., Ltd. romanized | 国药准字H201830012%(5g: 0.1g) | — | Official source ↗ |
| Hubei Cheng Tian Pharma Co., Ltd. romanized | 国药准字H201330672% | — | Official source ↗ |
| Guangdong Heng Jian Pharmaceutical Co., Ltd. romanized | 国药准字H201832942% | — | Official source ↗ |
| Hainan Quan Xing Pharmaceutical Co., Ltd. romanized | 国药准字H201930362%(5g:0.1g) | — | Official source ↗ |
| Hubei Cheng Tian Pharma Co., Ltd. romanized | 国药准字H201330672% | — | Official source ↗ |
| Beijing Jing Feng Pharmaceutical (Hebei) Co., Ltd. romanized | 国药准字H201830012%(5g: 0.1g) | — | Official source ↗ |
| Guangdong Heng Jian Pharmaceutical Co., Ltd. romanized | 国药准字H201832942% | — | Official source ↗ |
| Hainan Quan Xing Pharmaceutical Co., Ltd. romanized | 国药准字H201930362%(5g:0.1g) | — | Official source ↗ |
| Hubei Cheng Tian Pharma Co., Ltd. romanized | 国药准字H201330672% | — | Official source ↗ |
| Beijing Jing Feng Pharmaceutical (Hebei) Co., Ltd. romanized | 国药准字H201830012%(5g: 0.1g) | — | Official source ↗ |
| Hubei Cheng Tian Pharma Co., Ltd. romanized | 国药准字H201330672% | — | Official source ↗ |
| Guangdong Heng Jian Pharmaceutical Co., Ltd. romanized | 国药准字H201832942% | — | Official source ↗ |
| Hainan Quan Xing Pharmaceutical Co., Ltd. romanized | 国药准字H201930362%(5g:0.1g) | — | Official source ↗ |
| Hubei Cheng Tian Pharma Co., Ltd. romanized | 国药准字H201330672% | — | Official source ↗ |
| Beijing Jing Feng Pharmaceutical (Hebei) Co., Ltd. romanized | 国药准字H201830012%(5g: 0.1g) | — | Official source ↗ |
| Beijing Jing Feng Pharmaceutical (Hebei) Co., Ltd. romanized | 国药准字H201830012%(5g: 0.1g) | — | Official source ↗ |
| Beijing Jing Feng Pharmaceutical (Hebei) Co., Ltd. romanized | 国药准字H201830012%(5g: 0.1g) | — | Official source ↗ |
| Guizhou Lian Sheng Pharma Co., Ltd. romanized | 国药准字H202536382%(15g:0.3g) | — | Official source ↗ |
Under review 30
| Company (original) | Identifier (original) | Source date | Official source |
|---|---|---|---|
| TC Pharmaceuticals (Jiangsu) Co., Ltd | CYHS2600951 | 2026/04/23 | Official source ↗ |
| Hainan Feng Kai Si Pharmaceutical Co., Ltd. romanized; Nanjing Chen Gong Pharmaceutical Co., Ltd. romanized | CYHS2601044 | 2026/05/08 | Official source ↗ |
| Suzhou Di Si Pharmaceutical Factory Co., Ltd. romanized | CYHS2501859 | 2025/05/23 | Official source ↗ |
| Anhui Jie Xi Pharmaceuticals Co., Ltd. romanized | CYHS2602477 | 2026/10/10 | Official source ↗ |
| Henan Da Xin Pharma Co., Ltd. romanized | CYHS2602452 | 2026/10/09 | Official source ↗ |
| Zhejiang De En De Pharmaceutical Co., Ltd. romanized | CYHS2602338 | 2026/09/18 | Official source ↗ |
| Zhejiang De En De Pharmaceutical Co., Ltd. romanized | CYHS2602337 | 2026/09/18 | Official source ↗ |
| Zhejiang De En De Pharmaceutical Co., Ltd. romanized | CYHS2602336 | 2026/09/18 | Official source ↗ |
| Hubei Ke Yi Pharma Co., Ltd. romanized | CYHS2602173 | 2026/09/01 | Official source ↗ |
| Hangzhou Wan Bang Tian Cheng Pharma Co., Ltd. romanized | CYHS2602132 | 2026/08/26 | Official source ↗ |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | CYHS2602010 | 2026/08/13 | Official source ↗ |
| Shanghai Xiao Fang Pharmaceutical Co., Ltd. romanized | CYHS2601931 | 2026/08/07 | Official source ↗ |
| Shenzhen Shi Tai Li Biopharmaceuticals Co., Ltd. romanized; Shenzhen Shi Xin Yang Wei Kang Technology Co., Ltd. romanized | CYHB2601461 | 2026/07/30 | Official source ↗ |
| Shenzhen Shi Tai Li Biopharmaceuticals Co., Ltd. romanized; Shenzhen Shi Xin Yang Wei Kang Technology Co., Ltd. romanized | CYHB2601460 | 2026/07/30 | Official source ↗ |
| Shanxi Zhen Dong An Xin Biopharmaceutical Co., Ltd. romanized | CYHS2601655 | 2026/07/10 | Official source ↗ |
| Chengdu Ya Tu Bio Technology Co., Ltd. romanized; Hainan Hai Ling Chemical Pharmaceutical Co., Ltd. romanized | CYHS2601422 | 2026/06/16 | Official source ↗ |
| Jiangxi Shimei Pharmaceutical Co., Ltd | CYHB2601110 | 2026/06/12 | Official source ↗ |
| Jiangxi Shimei Pharmaceutical Co., Ltd | CYHB2601109 | 2026/06/12 | Official source ↗ |
| Jiangxi Pu Li Er Pharma Co., Ltd. romanized | CYHS2601302 | 2026/06/04 | Official source ↗ |
| Heilongjiang Tian Chen Pharma Co., Ltd. romanized | CYHS2600720 | 2026/03/26 | Official source ↗ |
| Beijing Cheng Ji Pharmaceutical Co., Ltd. romanized | CYHS2600154 | 2026/01/13 | Official source ↗ |
| Jiangxi Ji An San Li Pharmaceutical Co., Ltd. romanized | CYHS2600053 | 2026/01/06 | Official source ↗ |
| Hunan Jiudian Pharmaceutical Co., Ltd | CYHS2600010 | 2026/01/05 | Official source ↗ |
| Tang Shan Hong Xing Pharma Co., Ltd. romanized | CYHS2504158 | 2025/12/03 | Official source ↗ |
| Fujian Tai Ping Yang Pharmaceutical Co., Ltd. romanized | CYHS2504119 | 2025/12/02 | Official source ↗ |
| Zhejiang Kang Run Pharmaceutical Co., Ltd. romanized; Hangzhou Zhu Yang Xin Pharma Co., Ltd. romanized | CYHS2503180 | 2025/08/30 | Official source ↗ |
| Sui Cheng Pharma Co., Ltd. romanized | CYHS2503134 | 2025/08/27 | Official source ↗ |
| Hubei Chang Jiang Rui Yi Pharmaceuticals Technology Co., Ltd. romanized; Hunan Jiudian Pharmaceutical Co., Ltd | CYHS2503063 | 2025/08/20 | Official source ↗ |
| Shanghai Li Xiang Pharmaceutical Co., Ltd. romanized | CYHS2502835 | 2025/08/06 | Official source ↗ |
| Shanghai Li Xiang Pharmaceutical Co., Ltd. romanized | CYHS2502834 | 2025/08/06 | Official source ↗ |
Generic-filing companies this year 16
| Company (original) | Identifier (original) | Source date | Official source |
|---|---|---|---|
| TC Pharmaceuticals (Jiangsu) Co., Ltd | CYHS2600951 | 2026/04/23 | Official source ↗ |
| Hainan Feng Kai Si Pharmaceutical Co., Ltd. romanized; Nanjing Chen Gong Pharmaceutical Co., Ltd. romanized | CYHS2601044 | 2026/05/08 | Official source ↗ |
| Anhui Jie Xi Pharmaceuticals Co., Ltd. romanized | CYHS2602477 | 2026/10/10 | Official source ↗ |
| Henan Da Xin Pharma Co., Ltd. romanized | CYHS2602452 | 2026/10/09 | Official source ↗ |
| Zhejiang De En De Pharmaceutical Co., Ltd. romanized | CYHS2602338 | 2026/09/18 | Official source ↗ |
| Zhejiang De En De Pharmaceutical Co., Ltd. romanized | CYHS2602337 | 2026/09/18 | Official source ↗ |
| Zhejiang De En De Pharmaceutical Co., Ltd. romanized | CYHS2602336 | 2026/09/18 | Official source ↗ |
| Hubei Ke Yi Pharma Co., Ltd. romanized | CYHS2602173 | 2026/09/01 | Official source ↗ |
| Hangzhou Wan Bang Tian Cheng Pharma Co., Ltd. romanized | CYHS2602132 | 2026/08/26 | Official source ↗ |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | CYHS2602010 | 2026/08/13 | Official source ↗ |
| Shanghai Xiao Fang Pharmaceutical Co., Ltd. romanized | CYHS2601931 | 2026/08/07 | Official source ↗ |
| Shanxi Zhen Dong An Xin Biopharmaceutical Co., Ltd. romanized | CYHS2601655 | 2026/07/10 | Official source ↗ |
| Chengdu Ya Tu Bio Technology Co., Ltd. romanized; Hainan Hai Ling Chemical Pharmaceutical Co., Ltd. romanized | CYHS2601422 | 2026/06/16 | Official source ↗ |
| Jiangxi Pu Li Er Pharma Co., Ltd. romanized | CYHS2601302 | 2026/06/04 | Official source ↗ |
| Heilongjiang Tian Chen Pharma Co., Ltd. romanized | CYHS2600720 | 2026/03/26 | Official source ↗ |
| Beijing Cheng Ji Pharmaceutical Co., Ltd. romanized | CYHS2600154 | 2026/01/13 | Official source ↗ |
| Jiangxi Ji An San Li Pharmaceutical Co., Ltd. romanized | CYHS2600053 | 2026/01/06 | Official source ↗ |
| Hunan Jiudian Pharmaceutical Co., Ltd | CYHS2600010 | 2026/01/05 | Official source ↗ |
API companies with A status 9
| Company (original) | Identifier (original) | Source date | Official source |
|---|---|---|---|
| Zhejiang Rui Bang Pharma Co., Ltd. romanized | Y20240001329 | 2026/08/25 | Official source ↗ |
| Sheng Zhan Bio Technology Co., Ltd. romanized | Y20230001100 | 2026/04/21 | Official source ↗ |
| Fujian Kang Hong Bio Technology Co., Ltd. romanized | Y20240000479 | 2025/11/21 | Official source ↗ |
| Sichuan Nuo Yi Sheng Pharma Co., Ltd. romanized | Y20240000116 | 2025/11/01 | Official source ↗ |
| Hangzhou Zhong Mei Hua Dong Pharmaceutical Jiang Dong Co., Ltd. romanized | Y20210000384 | 2024/11/07 | Official source ↗ |
| Concord Biotech Limited | Y20200001497 | 2025/11/03 | Official source ↗ |
| Hangzhou Zhong Mei Hua Dong Pharmaceutical Co., Ltd. romanized | Y20190009554 | — | Official source ↗ |
| TAPI Hungary Industries Ltd. | Y20190009298 | 2025/05/01 | Official source ↗ |
| SmithKline Beecham Limited | Y20190009171 | — | Official source ↗ |
| Hangzhou Zhong Mei Hua Dong Pharmaceutical Co., Ltd. romanized | Y20190000308 | 2025/04/04 | Official source ↗ |
Trial registrations 2025/2026 —
Not loaded
Sources and dates
- FDA Orange Book
- 2026/11/06
- CDE acceptance and review
- 2026/11/13 06:42
- Chemical Drug Catalog
- 2026/11/13 06:39
- API registration records
- 2026/11/13 06:41
- NHSA drug code database
- 2026/10/23
- Trial registry
- 2026/11/13 08:09 · Incomplete coverage
Chinese counts use complete ingredient, dosage-form and route matches. Unmatched and partial rows show name-source matching only and make no finding about Chinese approvals or filings. Trials cover registration-number years 2025/2026 only.
Comparison generated: 2026/11/13 18:41 · openFDA Orange Book ↗
Name and dosage-form matching sources
- NMPA reference-product directory, Shaanxi MPA republication ↗ · 26-196 · 2019/06/04
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Sign in to subscribeYearly
US$1,920
Billed every year
US$160 per month
Sign in to subscribeNeed more than 10 followed products or more than 5 recipients? Contact us.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
Billed by Creem, our merchant of record · Terms · Refund policy